Similar Items: Recent advances in incretin biology and therapeutics: From glucose‐dependent insulinotropic polypeptide reappraisal to next‐generation agonists
- c‐Jun N‐terminal kinase 3 as a permissive regulator of β‐cell incretin responsiveness
- Glucagon-Like Peptide-1 Receptor Agonists: Their Potential Role in Prediabetes
- Five‐year follow‐up of incretin‐based therapy in a patient with KCNJ11‐related permanent neonatal diabetes: Achieving insulin discontinuation and sulfonylurea reduction
- Cost‐effectiveness analysis comparing real‐time continuous glucose monitoring with self‐monitoring of blood glucose for patients with type 2 diabetes treated with insulin in Japan
- Factors associated with discrepancy between glycated hemoglobin and glucose management indicator
- Blood Glucose Monitoring Expert Group and Best Practice Recommendation—FITTER BiG